NIH-funded research NIH-funded research

Next-generation physiology tools for human gut microbiome research

Official title: Developing Next-Generation Physiology approaches for human gut microbiome research

Funded at Montana State University - Bozeman · NIH-11364207 · Data updated 2026-11-12

Researchers are developing cutting-edge, single-cell methods to study how gut microbes function in their natural, in-body environment to better understand gut health and disease.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionMontana State University - Bozeman
NIH-funded
Lab location1 site (Bozeman, United States)
Project startAugust 8, 2022
Project endJuly 31, 2027
Funding year2026
Award (this year)$360,000
NIH project number5R35GM147166-05
Project IDNIH-11364207 on NIH RePORTER

Who could benefit from this research

Could help

Individuals undergoing gut biopsy or GI procedures who have or are at risk for gut-related conditions could potentially benefit from insights gained.

Less likely to help

Healthy individuals or those not participating in GI biopsies may not directly benefit from the findings.

What this research studies

This grant aims to bring single-cell precision to studying the human gut microbiome, focusing on how individual microbes behave within the mucosal environment. The team will use advanced techniques like substrate analog probing, bioorthogonal labeling, and fluorescence in situ hybridization, together with cell-sorting, to map metabolic activity in gut microbes. By studying biopsy samples directly from the GI tract, the project seeks to preserve spatial context and inter-microbial relationships that bulk methods miss. The ultimate goal is to reveal how specific microbes contribute to gut function and health in humans.

Why it matters

Potential benefit: If successful, patients could benefit from a deeper understanding of gut microbiome function that informs new diagnostics or therapies for GI conditions.

How similar studies have gone: Single-cell approaches are rapidly advancing in microbiome research, with promising results in related fields, but this application to human gut mucosal samples is an emerging area.

Where this research is happening

  • Montana State University - Bozeman
    Bozeman, United States
    Active

Researchers

  • Principal investigator: Hatzenpichler, Roland — Montana State University - Bozeman
  • Study coordinator: Hatzenpichler, Roland

Related research

Other NIH-funded projects on the same topics.

  • Multi-agent AI to annotate enzymes in the human gut microbiome

    A team at a major university will build an AI system that automatically curates and labels the functions of enzymes in the human gut microbiome to speed up understanding their health effects.

    NIH research University of South Florida · Tampa, United States · NIH-11594384

  • Mapping how gut bacteria transform drugs

    Scientists will study how the gut microbiome changes thousands of drugs into new forms, which could affect how well a medicine works or whether it causes side effects.

    NIH research Stanford University · Stanford, United States · NIH-11550022

  • Aflatoxin exposure and child growth in Guatemala

    A study in rural Guatemala will track how exposure to aflatoxin relates to growth and gut health in young children.

    NIH research Arizona State University-Tempe Campus · Scottsdale, United States · NIH-11513260

  • Gut bacteria that can make cancer immunotherapy less effective

    This project will see if reducing chronic inflammation driven by certain gut bacteria can help immunotherapy work better for people whose cancers have stopped responding.

    NIH research University of Tx Md Anderson Can Ctr · Houston, United States · NIH-11478145

  • How gut bacteria affect how cancer drugs work

    This project looks at how the bacteria in your gut might change how well and with what side effects fluoropyrimidine cancer drugs like 5-FU work in people.

    NIH research University of California, San Francisco · San Francisco, United States · NIH-11473234

  • Gut bacteria and cancer drugs: how your gut may change chemotherapy effectiveness

    This project studies how the gut microbiome might affect how well certain chemotherapy drugs work and their side effects in people with cancer.

    NIH research University of California, San Francisco · San Francisco, United States · NIH-11473233

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.